Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide

Paul Han, Richard A. Drachtman, Peter Amenta, Lawrence J. Ettinger

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Purpose: Primary cardiac leiomyosarcoma is a rare malignant tumor in childhood. Patients with unresectable or partially resected cardiac leiomyosarcoma typically have a poor prognosis. The role of chemotherapy in the treatment of these patients has not been well defined. Patient and Methods: A 6-week-old infant with an incompletely resected cardiac leiomyosarcoma was treated postoperatively with ifosfamide and etoposide. Results: The patient is disease-free and without apparent late effects 5 years following the completion of therapy. Conclusion: The combination of ifosfamide and etoposide warrants further evaluation in patients with leiomyosarcoma.

Original languageEnglish (US)
Pages (from-to)314-317
Number of pages4
JournalJournal of Pediatric Hematology/Oncology
Volume18
Issue number3
DOIs
StatePublished - 1996

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Keywords

  • Cardiac sarcoma
  • Chemotherapy
  • Etoposide
  • Ifosfamide
  • Leiomyosarcoma

Fingerprint Dive into the research topics of 'Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide'. Together they form a unique fingerprint.

Cite this